• A feasibility study at UNSW Sydney investigated cannabidiol (CBD) for managing cannabis withdrawal symptoms during inpatient detoxification.
• The study used a single-subject repeated measures design, assessing participants at baseline and after CBD intervention over a week.
• CBD was found to be acceptable and safe, even at doses up to 1200mg/day, with no reported adverse events.
• The positive results support further research, including double-blind randomized controlled trials, to confirm CBD's effectiveness.